6.
Mathew A, Goyal V, George E, Thekkemuriyil D, Jayakumar B, Chopra A
. Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract. 2011; 65(12):1306-12.
DOI: 10.1111/j.1742-1241.2011.02792.x.
View
7.
Bouquillard E, Fianu A, Bangil M, Charlette N, Ribera A, Michault A
. Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (RHUMATOCHIK study). Joint Bone Spine. 2017; 85(2):207-210.
DOI: 10.1016/j.jbspin.2017.01.014.
View
8.
Segura-Charry J, Parada-Martinez M, Segura-Puello H, Munoz-Forero D, Nieto-Mosquera D, Villamil-Ballesteros A
. Musculoskeletal disorders due to chikungunya virus: A real experience in a rheumatology department in Neiva, Huila. Reumatol Clin (Engl Ed). 2021; 17(8):456-460.
DOI: 10.1016/j.reumae.2020.04.003.
View
9.
Rodrigo C, Herath T, Wickramarachchi U, Fernando D, Rajapakse S
. Treatment of chikungunya-associated joint pain: a systematic review of controlled clinical trials. Trans R Soc Trop Med Hyg. 2022; 116(10):889-899.
DOI: 10.1093/trstmh/trac045.
View
10.
Manimunda S, Vijayachari P, Uppoor R, Sugunan A, Singh S, Rai S
. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg. 2010; 104(6):392-9.
DOI: 10.1016/j.trstmh.2010.01.011.
View
11.
Ravindran V, Alias G
. Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study. Clin Rheumatol. 2016; 36(6):1335-1340.
DOI: 10.1007/s10067-016-3429-0.
View
12.
Ferreira de Almeida I, Codeco C, Lana R, Soares Bastos L, de Souza Oliveira S, Andreza da Cruz Ferreira D
. The expansion of chikungunya in Brazil. Lancet Reg Health Am. 2023; 25:100571.
PMC: 10448323.
DOI: 10.1016/j.lana.2023.100571.
View
13.
Munn Z, Barker T, Moola S, Tufanaru C, Stern C, McArthur A
. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020; 18(10):2127-2133.
DOI: 10.11124/JBISRIR-D-19-00099.
View
14.
Amaral J, Taylor P, Schoen R
. Bone erosions and joint damage caused by chikungunya virus: a systematic review. Rev Soc Bras Med Trop. 2024; 57:e00404.
PMC: 11000508.
DOI: 10.1590/0037-8682-0433-2023.
View
15.
Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham 3rd C
. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9):2569-81.
DOI: 10.1002/art.27584.
View
16.
Wahid B, Ali A, Rafique S, Idrees M
. Global expansion of chikungunya virus: mapping the 64-year history. Int J Infect Dis. 2017; 58:69-76.
DOI: 10.1016/j.ijid.2017.03.006.
View
17.
Scherer H, Haupl T, Burmester G
. The etiology of rheumatoid arthritis. J Autoimmun. 2020; 110:102400.
DOI: 10.1016/j.jaut.2019.102400.
View
18.
Bezerra L, da Silva Bastos Y, Goncales J, Silva Junior J, Lorena V, Duarte A
. Synergism between chikungunya virus infection and rheumatoid arthritis on cytokine levels: Clinical implications?. Braz J Microbiol. 2023; 54(2):885-890.
PMC: 10234957.
DOI: 10.1007/s42770-023-00976-6.
View
19.
Costa L, de Almeida Barreto F, Barreto M, Santos T, Andrade M, Farias L
. Epidemiology and Economic Burden of Chikungunya: A Systematic Literature Review. Trop Med Infect Dis. 2023; 8(6).
PMC: 10302198.
DOI: 10.3390/tropicalmed8060301.
View
20.
Tritsch S, Encinales L, Pacheco N, Cadena A, Cure C, McMahon E
. Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting Symptoms. J Rheumatol. 2019; 47(8):1267-1274.
PMC: 7938419.
DOI: 10.3899/jrheum.190162.
View